Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Letters

Latest Letters

vax_lettertogaviboard_22june2020-final_page_1_3
Letter |
23 June 2020
COVID-19

Open letter to Gavi Board Members: Urgent changes to COVAX Facility design required to ensure access to COVID-19 vaccines for all

COVID Belgium campaign hospital
Letter
Letter |
16 June 2020
COVID-19

Stop all trade and investment treaty negotiations during the COVID-19 outbreak and refocus on access to medical supplies and saving lives

Letter |
22 May 2020
COVID-19
Brazil

Letter to Brazilian parliament on compulsory licenses for COVID-19 medical tools

An MSF Health Promoter speaks with people about how to keep safe during the COVID-19 pandemic.
Letter
Letter |
19 May 2020
Intellectual property and trade
South Africa

South Africa’s patent laws threaten access to future COVID-19 medicines

Letter |
18 May 2020
COVID-19

COVID-19 – CSO open letter to UNITAID, the World Health Organization (WHO) and its Member States

MSF Logistician Eric Schimdt prepares dozens of cellphones for distribution. MSF’s COVID-19 team in New York City is distributing 1,000 cellphones to people who are currently homeless and housing insecure so they can contact emergency, medical and social services.
Letter
Letter |
16 May 2020
COVID-19

WHO and Unitaid must ensure binding commitments for equitable access to COVID-19 technologies

La ampliación de camas mediante un pabellón cercano al Hospital de Alcalá de Henares está lista para su traspaso al hospital.
Letter
Letter |
24 April 2020
COVID-19
Global

COVID-19: Principles for Global Access, Innovation and Cooperation

The MSF treatment centre for COVID-19 patients at the Amirou Boubacar Diallo National Hospital in Niamey, Niger, has 50 beds, with the potential to accommodate up to 100 beds in case of a peak in patient numbers. The semi-permanent structure is completely autonomous to treat patients and limit the risk of transmission to the neighbouring hospital.
Letter
Letter |
18 April 2020
COVID-19

Letter to Trade Ministries and WTO: Stop all trade and investment treaty negotiations during the COVID-19 outbreak

  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury